The Three Core Value Propositions:
The Three Core Value Propositions:
The Three Core Value Propositions:
1. Expand Your Pharmacopeia with Novel Mechanisms of Action
Standard of care is evolving. Move beyond the limitations of generic Minoxidil and Finasteride by offering your patients a modern, multi-modal formulary that targets hair loss pathways previously left untreated.
Superior Efficacy: Deploy 0.05% Topical Dutasteride, clinically proven to demonstrate superior efficacy compared to oral Finasteride (1mg) in increasing target area hair count.
Poly-Therapy Approach: Access novel compounds like Bimatoprost (Prostaglandin analog), Cetirizine (PGD2 inhibition), and Procyanidin B2 (TGF-β inhibition) to tackle non-responders.
Combat Tolerance: Offer scientifically backed alternatives for patients who have plateaued on traditional therapies.
3. Zero-Touch Operations & Passive Practice Revenue
Scale your practice’s revenue without scaling your workload. Rx Licensing operates as a complete Management Services Organization (MSO), handling the logistics so you can focus on patient outcomes.
Turnkey Infrastructure: We provide the tech stack (Framer-based frontend), the Merchant of Record (MoR) billing via Stripe, and the compliant independent prescriber network.
No Operational Headache: We manage the entire lifecycle—from secure patient intake and 503A pharmacy fulfillment to shipping and refill management. You hold no inventory and manage no logistics.
High-Margin Royalties: Receive significant licensing royalties (70% of program profits) for your brand and patient funnel, turning your clinic’s traffic into a recurring, passive revenue stream.
2. Precision Dosing & Systemic Safety via Optimized Delivery
We don’t just provide ingredients; we provide optimized bioavailability. Our formulations are engineered to maximize efficacy at the follicle while strictly minimizing systemic absorption—solving the compliance issues caused by side effects.
Safety First: Our topical Dutasteride formulations are clinically shown to maintain serum DHT and testosterone levels, avoiding the systemic hormonal suppression associated with oral 5-AR inhibitors.
Vehicle Technology: Utilizing data-driven vehicles (such as Bimatoprost Formulation A), we ensure the active compound penetrates the stratum corneum effectively to reach the dermal papilla.
Custom Compounding: Precise concentration adjustments allow you to tailor treatments to patient sensitivity and severity, far beyond what off-the-shelf pharmaceuticals can offer.
We don’t just provide ingredients; we provide optimized bioavailability. Our formulations are engineered to maximize efficacy at the follicle while strictly minimizing systemic absorption—solving the compliance issues caused by side effects.
Safety First: Our topical Dutasteride formulations are clinically shown to maintain serum DHT and testosterone levels, avoiding the systemic hormonal suppression associated with oral 5-AR inhibitors.
Vehicle Technology: Utilizing data-driven vehicles (such as Bimatoprost Formulation A), we ensure the active compound penetrates the stratum corneum effectively to reach the dermal papilla.
Custom Compounding: Precise concentration adjustments allow you to tailor treatments to patient sensitivity and severity, far beyond what off-the-shelf pharmaceuticals can offer.
3. Zero-Touch Operations & Passive Practice Revenue
Scale your practice’s revenue without scaling your workload. Rx Licensing operates as a complete Management Services Organization (MSO), handling the logistics so you can focus on patient outcomes.
Turnkey Infrastructure: We provide the tech stack (Framer-based frontend), the Merchant of Record (MoR) billing via Stripe, and the compliant independent prescriber network.
No Operational Headache: We manage the entire lifecycle—from secure patient intake and 503A pharmacy fulfillment to shipping and refill management. You hold no inventory and manage no logistics.
High-Margin Royalties: Receive significant licensing royalties (70% of program profits) for your brand and patient funnel, turning your clinic’s traffic into a recurring, passive revenue stream.
Rx Licensing vs. Alternatives
Rx Licensing
vs. Alternatives
Rx Licensing
vs. Alternatives
Comparison
Rx Licensing (Our Program)
Do It Yourself (In-House)
Standard Compounding Pharmacy
Mass Market (Hims/Ro)
Formulary
Advanced. Topical Dutasteride 0.05%, Bimatoprost, Cetirizine.
Standard. Limited to your personal knowledge & sourcing.
Basic. Mostly Minoxidil + Finasteride variants.
Generic. Basic Oral Finasteride & Minoxidil foam.
Delivery & Dosing
Precision & Targeted. Custom dosing in custom vehicles. Delivers to the follicle while preventing systemic absorption.
Variable. Dosing accuracy depends on staff. Difficult to compound stable, advanced vehicles in-house.
Fixed & Generic. Limited strengths. Uses cheap alcohol bases that cause irritation and poor absorption.
Systemic & Rigid. Oral pills flood the body. One fixed dose (1mg) for all. High risk of sexual side effects.
Operations
100% Passive. We handle all operations such as billing, support, & shipping. and support with marketing
Heavy Lift. You manage inventory, staff, software & logistics.
High Friction. You must manually write/fax every single script.
Zero Effort. You hand the patient off entirely.
Economics
High & Recurring. You keep 70% of profit monthly.
High Overhead. Staff, tech, & legal costs eat your margins.
Low Margin. Admin time per script destroys clinic profitability.
Low Value. One-time referral fee (~$40). No recurring value.
Brand
Yours. White-labeled to build your clinic equity.
Yours. But requires expensive custom dev ($50k+).
The Pharmacy's. Labels highlight them, confusing the patient.
The Competitor's. You actively lose the patient relationship.
Comparison
Rx Licensing (Our Program)
Do It Yourself (In-House)
Standard Compounding Pharmacy
Mass Market (Hims/Ro)
Formulary
Advanced. Topical Dutasteride 0.05%, Bimatoprost, Cetirizine.
Standard. Limited to your personal knowledge & sourcing.
Basic. Mostly Minoxidil + Finasteride variants.
Generic. Basic Oral Finasteride & Minoxidil foam.
Delivery & Dosing
Precision & Targeted. Custom dosing in custom vehicles. Delivers to the follicle while preventing systemic absorption.
Variable. Dosing accuracy depends on staff. Difficult to compound stable, advanced vehicles in-house.
Fixed & Generic. Limited strengths. Uses cheap alcohol bases that cause irritation and poor absorption.
Systemic & Rigid. Oral pills flood the body. One fixed dose (1mg) for all. High risk of sexual side effects.
Operations
100% Passive. We handle all operations such as billing, support, & shipping. and support with marketing
Heavy Lift. You manage inventory, staff, software & logistics.
High Friction. You must manually write/fax every single script.
Zero Effort. You hand the patient off entirely.
Economics
High & Recurring. You keep 70% of profit monthly.
High Overhead. Staff, tech, & legal costs eat your margins.
Low Margin. Admin time per script destroys clinic profitability.
Low Value. One-time referral fee (~$40). No recurring value.
Brand
Yours. White-labeled to build your clinic equity.
Yours. But requires expensive custom dev ($50k+).
The Pharmacy's. Labels highlight them, confusing the patient.
The Competitor's. You actively lose the patient relationship.
Comparison
Rx Licensing (Our Program)
Do It Yourself (In-House)
Standard Compounding Pharmacy
Mass Market (Hims/Ro)
Formulary
Advanced. Topical Dutasteride 0.05%, Bimatoprost, Cetirizine.
Standard. Limited to your personal knowledge & sourcing.
Basic. Mostly Minoxidil + Finasteride variants.
Generic. Basic Oral Finasteride & Minoxidil foam.
Delivery & Dosing
Precision & Targeted. Custom dosing in custom vehicles. Delivers to the follicle while preventing systemic absorption.
Variable. Dosing accuracy depends on staff. Difficult to compound stable, advanced vehicles in-house.
Fixed & Generic. Limited strengths. Uses cheap alcohol bases that cause irritation and poor absorption.
Systemic & Rigid. Oral pills flood the body. One fixed dose (1mg) for all. High risk of sexual side effects.
Operations
100% Passive. We handle all operations such as billing, support, & shipping. and support with marketing
Heavy Lift. You manage inventory, staff, software & logistics.
High Friction. You must manually write/fax every single script.
Zero Effort. You hand the patient off entirely.
Economics
High & Recurring. You keep 70% of profit monthly.
High Overhead. Staff, tech, & legal costs eat your margins.
Low Margin. Admin time per script destroys clinic profitability.
Low Value. One-time referral fee (~$40). No recurring value.
Brand
Yours. White-labeled to build your clinic equity.
Yours. But requires expensive custom dev ($50k+).
The Pharmacy's. Labels highlight them, confusing the patient.
The Competitor's. You actively lose the patient relationship.
Modern Pharmacology for Androgenetic Alopecia
Literature Review and Commercial Solutions in 2025
Procyanidin B2
Counteracts TGF-β
Cetirizine HCl
Shifts prostaglandin D2/E2 balance
Sulforaphane
Accerelates enzymatic DHT degradation
Bimotoprost
Prostaglandin F2α analog
Equol
Binds directly and specifically to DHT
Procyanidin B2
Counteracts TGF-β
Cetirizine HCl
Shifts prostaglandin D2/E2 balance
Sulforaphane
Accerelates enzymatic DHT degradation
Bimotoprost
Prostaglandin F2α analog
Equol
Binds directly and specifically to DHT
Procyanidin B2
Counteracts TGF-β
Cetirizine HCl
Shifts prostaglandin D2/E2 balance
Sulforaphane
Accerelates enzymatic DHT degradation
Bimotoprost
Prostaglandin F2α analog
Equol
Binds directly and specifically to DHT
Challenge 1: Finasteride Safety Concerns at All Time Highs
Challenge 2: Androgenetic alopecia is multi-factorial
Source: Herman, A., Herman, A.P., 2016. Mechanism of action of herbs and their active constituents used in hair loss treatment. Fitoterapia 114, 18-25.
Opportunity: While Options are Stagnant, Research is Exploding
Finasteride was introduced in 1992 for BPH and minoxidil in 1988.
Literature Review & Applicable Pharmacology
Modern active ingredients, supported by extensive and replicated clinical data.
Procyanindin B2
The most potent B-type procyanidin for hair growth. Included in systemK11
Mechanism of Action
Counters TGF-β-induced telogen, elongating anagen
Best Practices for Formulations
Oral administration in gastric-resistant capsules, at 400mg BID. Pharmacokinetic enhancer (e.g. piperine) is recommended.
Study Citation
Participants, Duration & Design
Dose & Administration Route
Efficacy Outcomes
Safety, Adverse Events & Notes
De Biasio 2023; Yeniay 2022; Tenore 2018; Takahashi 2005; Takahashi 2001
442 adults; 2–6-month double-blind randomised controlled trials
400 mg BID (Procyanidin B2-enriched) or topical 0.7–1% BID
Topical: +13.8 to +24.8 hairs/cm² vs placebo (p<0.001); Oral: +14 to +19.2 hairs/cm² (significant); consistent gains across studies
Excellent tolerability; no serious AEs; occasional mild local scaling/itching with topical
Review studies in detail
Procyanindin B2
The most potent B-type procyanidin for hair growth. Included in systemK11
Mechanism of Action
Counters TGF-β-induced telogen, elongating anagen
Best Practices for Formulations
Oral administration in gastric-resistant capsules. Pharmacokinetic enhancer (e.g. piperine) is recommended.
Study Citation
Participants, Duration & Design
Dose & Administration Route
Efficacy Outcomes
Safety, Adverse Events & Notes
De Biasio 2023; Yeniay 2022; Tenore 2018; Takahashi 2005; Takahashi 2001
442 adults; 2–6-month double-blind randomised controlled trials
400 mg BID (Procyanidin B2-enriched) or topical 0.7–1% BID
Topical: +13.8 to +24.8 hairs/cm² vs placebo (p<0.001); Oral: +14 to +19.2 hairs/cm² (significant); consistent gains across studies
Excellent tolerability; no serious AEs; occasional mild local scaling/itching with topical
Review studies in detail
Procyanindin B2
The most potent B-type procyanidin for hair growth. Included in systemK11
Mechanism of Action
Counters TGF-β-induced telogen, elongating anagen
Best Practices for Formulations
Oral administration in gastric-resistant capsules. Pharmacokinetic enhancer (e.g. piperine) is recommended.
De Biasio 2023; Yeniay 2022; Tenore 2018; Takahashi 2005; Takahashi 2001
442 adults; 2–6-month double-blind randomised controlled trials
400 mg BID (Procyanidin B2-enriched) or topical 0.7–1% BID
Topical: +13.8 to +24.8 hairs/cm² vs placebo (p<0.001); Oral: +14 to +19.2 hairs/cm² (significant); consistent gains across studies
Excellent tolerability; no serious AEs; occasional mild local scaling/itching with topical
Review studies in detail
Bimatoprost
FDA-approved drug for glaucoma and eyelash hypotrichosis by increasing eyelash length & thickness.
Mechanism of Action
Prostaglandin F2α analog, elongating anagen
Best Practices for Formulations
0.3% bimatoprost showed the best results. Penetration enhancers are also recommended.
Study Citation
Participants, Duration & Design
Dose & Administration Route
Efficacy Outcomes
Safety, Adverse Events (AEs) & Notes
NCT01904721; NCT02170662; NCT01325337; NCT01325350; Aryaningrum 2018
874 adults with AGA; mostly 4–6-mo, double-blind Phase II RCTs; plus a small crossover and a single-arm
Topical 0.03–0.3% bimatoprost QD–BID; controls: placebo and 2–5% minoxidil
Best men’s arm: +13.1 hairs/cm² vs +4.1 placebo (p=0.005); Crossover +27.4% on-drug; small single-arm ↑ vellus diameter 88%; women’s not significant vs placebo;
Mostly mild local AEs (pruritus/dryness); some hypertrichosis; URTIs/rare serious events reported but judged unrelated; overall well tolerated
Review studies in detail
Bimatoprost
FDA-approved drug for glaucoma and eyelash hypotrichosis by increasing eyelash length & thickness.
Mechanism of Action
Prostaglandin F2α analog, elongating anagen
Best Practices for Formulations
0.3% bimatoprost showed the best results. Penetration enhancers are also recommended.
Study Citation
Participants, Duration & Design
Dose & Administration Route
Efficacy Outcomes
Safety, Adverse Events (AEs) & Notes
NCT01904721; NCT02170662; NCT01325337; NCT01325350; Aryaningrum 2018
874 adults with AGA; mostly 4–6-mo, double-blind Phase II RCTs; plus a small crossover and a single-arm
Topical 0.03–0.3% bimatoprost QD–BID; controls: placebo and 2–5% minoxidil
Best men’s arm: +13.1 hairs/cm² vs +4.1 placebo (p=0.005); Crossover +27.4% on-drug; small single-arm ↑ vellus diameter 88%; women’s not significant vs placebo;
Mostly mild local AEs (pruritus/dryness); some hypertrichosis; URTIs/rare serious events reported but judged unrelated; overall well tolerated
Review studies in detail
Bimatoprost
FDA-approved drug for glaucoma and eyelash hypotrichosis by increasing eyelash length & thickness.
Mechanism of Action
Prostaglandin F2α analog, elongating anagen
Best Practices for Formulations
0.3% bimatoprost showed the best results. Penetration enhancers are also recommended.
NCT01904721; NCT02170662; NCT01325337; NCT01325350; Aryaningrum 2018
874 adults with AGA; mostly 4–6-mo, double-blind Phase II RCTs; plus a small crossover and a single-arm
Topical 0.03–0.3% bimatoprost QD–BID; controls: placebo and 2–5% minoxidil
Best men’s arm: +13.1 hairs/cm² vs +4.1 placebo (p=0.005); Crossover +27.4% on-drug; small single-arm ↑ vellus diameter 88%; women’s not significant vs placebo;
Mostly mild local AEs (pruritus/dryness); some hypertrichosis; URTIs/rare serious events reported but judged unrelated; overall well tolerated
Review studies in detail
Cetirizine
FDA-approved antihistamine drug for allergies and hives, available OTC since 2007.
Mechanism of Action
Shifts prostaglandins balance (↓ PGD2, ↑ PGE2) and acts as an anti-inflammatory
Best Practices for Formulations
1% cetirizine HCl for improved solubility
Study Citation
Participants, Duration & Design
Dose & Administration Route
Efficacy Outcomes
Safety, Adverse Events (AEs) & Notes
Bassiouny 2022; Mostafa 2021; Zaky 2021; Rossi 2018
251 adults; 4–6-mo blinded randomised controlled trials and one pilot
1% topical cetirizine QD–BID; sometimes added to 5% minoxidil
Monotherapy: +8.5 to +30.3 hairs/cm² vs placebo; 43% new growth vs 0% placebo; as add-on, minoxidil + cetirizine > minoxidil + placebo (p<0.05)
Well tolerated; no systemic signals; AEs sparsely detailed in some trials
Review studies in detail
Cetirizine
FDA-approved antihistamine drug for allergies and hives, available OTC since 2007.
Mechanism of Action
Shifts prostaglandins balance (↓ PGD2, ↑ PGE2) and acts as an anti-inflammatory
Best Practices for Formulations
1% cetirizine HCl for improved solubility
Study Citation
Participants, Duration & Design
Dose & Administration Route
Efficacy Outcomes
Safety, Adverse Events (AEs) & Notes
Mostafa 2021; Bassiouny 2022; Zaky 2021; Rossi 2018
251 adults; 4–6-mo blinded randomised controlled trials and one pilot
1% topical cetirizine QD–BID; sometimes added to 5% minoxidil
Monotherapy: +8.5 to +30.3 hairs/cm² vs placebo; 43% new growth vs 0% placebo; as add-on, minoxidil + cetirizine > minoxidil + placebo (p<0.05)
Well tolerated; no systemic signals; AEs sparsely detailed in some trials
Review studies in detail
Cetirizine
FDA-approved antihistamine drug for allergies and hives, available OTC since 2007.
Mechanism of Action
Shifts prostaglandins balance (↓ PGD2, ↑ PGE2) and acts as an anti-inflammatory
Best Practices for Formulations
1% cetirizine HCl for improved solubility
Mostafa 2021; Bassiouny 2022; Zaky 2021; Rossi 2018
251 adults; 4–6-mo blinded randomised controlled trials and one pilot
1% topical cetirizine QD–BID; sometimes added to 5% minoxidil
Monotherapy: +8.5 to +30.3 hairs/cm² vs placebo; 43% new growth vs 0% placebo; as add-on, minoxidil + cetirizine > minoxidil + placebo (p<0.05)
Well tolerated; no systemic signals; AEs sparsely detailed in some trials
Review studies in detail
Modern ingredients, supported by smaller data sets or unique mechanisms of action
Adenosine
Naturally occurring nucleoside
Mechanism of Action
Promotes pro-anagen signalling through adenosine receptor activation at DP
Best Practices for Formulations
0.75% in aqueous-based solution for twice daily application
Tocotrienols
Potent anti-oxidants in the vitamin E family. Included in systemK11
Mechanism of Action
Antioxidant - reduces oxidative linked with alopecia and TGF-beta expression.
Best Practices for Formulations
High-dose oral vitamin E has risks. Sub-15 mg/day suggested. Combine with astaxanthin or ergothioneine which directly improve mitochondrial function.
Rice Bran Extract
Topical phytosterol-rich extract that increases hair density in a rigorous human study.
Mechanism of Action
5-alpha reductase inhibition, via phytosterol derivatives.
Best Practices for Formulations
Topical application, with rice bran extracted via supercritical CO2.
Fenugreek Seed Extract
A culinary and medicinal seed rich in saponins, fibre, and nutrients; used traditionally for digestion and metabolism.
Included in systemK11
Mechanism of Action
Steroidal saponins may blunt DHT activity and glucose metabolism modulation through 4-HIL.
Best Practices for Formulations
Oral administration. Standardised seed extracts for both saponin and soluble dietary fibre (galactomannan).
Sulforaphane glucosinolate
A broccoli-derived isothiocyanate.
Included in systemK11
Mechanism of Action
Upregulates 3α-HSD, an enzyme that degrades DHT into less damaging metabolites.
Best Practices for Formulations
Oral administration of sulforaphane glucosinolate (sulforaphane precursor) co-administered with myrosinase enzyme.
Equol
A metabolite of a legume isoflavone.
Currently used in prostate health.
Mechanism of Action
Reversibly binds to DHT directly with high specificity,
Best Practices for Formulations
Topical applications prevent equol from being conjugated. Dose-ranging and delivery studies are needed.
Review studies in detail
Adenosine
Naturally occurring nucleoside
Mechanism of Action
Promotes pro-anagen signalling through adenosine receptor activation at DP
Best Practices for Formulations
0.75% in aqueous-based solution for twice daily application
Tocotrienols
Potent anti-oxidants in the vitamin E family. Included in systemK11
Mechanism of Action
Antioxidant - reduces oxidative linked with alopecia and TGF-beta expression
Best Practices for Formulations
Long-term high-dose vitamin E has risks. Sub-15 mg/day suggested. Combine with astaxanthin or ergothioneine which are associated with longevity.
Rice Bran Extract
Topical phytosterol-rich extract that increases hair density in a rigorous human study.
Mechanism of Action
5-alpha reductase inhibition, via phytosterol derivatives
Best Practices for Formulations
Topical application, with rice bran extracted via supercritical CO2.
Fenugreek Seed Extract
A culinary and medicinal seed rich in saponins, fibre, and nutrients; used traditionally for digestion and metabolism.
Included in systemK11
Mechanism of Action
Steroidal saponins may blunt DHT activity and glucose metabolism modulation through 4-HIL
Best Practices for Formulations
Standardised seed extracts for both saponin and soluble dietary fibre (galactomannan)
Sulforaphane glucosinolate
A broccoli-derived isothiocyanate.
Included in systemK11
Mechanism of Action
Upregulates 3α-HSD, an enzyme that degrades DHT into less damaging metabolites
Best Practices for Formulations
Oral administration of sulforaphane glucosinolate (sulforaphane precursor) co-administered with myrosinase enzyme.
Equol
A metabolite of a legume isoflavone.
Currently used in prostate health.
Mechanism of Action
Specifically binds to DHT directly, reducing androgen receptor activation
Best Practices for Formulations
Topical applications prevent equol from being conjugated. Dose-ranging and delivery studies are needed.
Review studies in detail
Adenosine
Naturally occurring nucleoside
Tocotrienols
Potent anti-oxidants in the vitamin E family. Included in systemK11
Rice Bran Extract
Topical phytosterol-rich extract that increases hair density in a rigorous human study.
Fenugreek Seed Extract
A culinary and medicinal seed rich in saponins, fibre, and nutrients; used traditionally for digestion and metabolism.
Included in systemK11
Sulforaphane glucosinolate
A broccoli-derived isothiocyanate.
Included in systemK11
Equol
A metabolite of a legume isoflavone.
Currently used in prostate health.
Review studies in detail
Part 2: Simplifying your Telemedicine Brand Journey
Do-It-Yourself Approach
Pharmaceutical Line (currently US enabled)
Your Branding & Website
Multi-state telehealth setup
Prescriber &
pharmacy
E-prescribe, billing & logistics
Ongoing marketing, reporting & research
World class therapies
Au Naturel Line
Your Branding & Website
Clinic-specific formulation
Analytical chemistry quality assurance
E-commerce setup & logistics
Ongoing marketing, reporting & research
World class therapies
Turnkey Bespoke Licensing
Your own pharmaceutical & au naturel line
WE TAKE CARE OF THAT
WE TAKE CARE OF THAT
WE TAKE CARE OF THAT
World class therapies
Turnkey Bespoke Licensing Programmes
Two Licensing Options, One Turnkey System
Pharmaceutical | Non-Pharmaceutical
01
01
01
Your vision, our end-to-end execution
You control the brand and formulas. We handle execution end-to-end and provide ongoing access to our IP and scientists.
02
02
02
You pay a simple setup fee and royalty
A one-time fee and an ongoing royalty ensuring interests align.
03
03
03
Products supplied at zero markup
All products are supplied at the true production cost and clinics can purchase directly from suppliers.
04
04
04
You keep most of the profits & improve patient outcomes
Licensing agreement ensures clinics keep at least 70% of gross profits, with no extra fees or surprise costs.
With research into androgenetic alopecia growing exponentially, the gap between pharmacology treatments patients receive and what they deserve is widening. Mainstream telemedicine is lagging, and the regulatory landscape of non-pharmaceuticals leave the quality burden on manufacturer, and is rarely fulfilled.
Both licensing programmes, offered to only discerning hair restoration clinics. enable the creation of differentiated therapies such as 0.3% topical bimatoprost, or 50mg of standardised oral procyanidin B2 that are found nowhere else - in addition to mainstream therapies like finasteride. Clinics generating profits and improve outcomes while staying focused on what they do best.
With research into androgenetic alopecia growing exponentially, the gap between pharmacology treatments patients receive and what they deserve is widening. Mainstream telemedicine is lagging, and the regulatory landscape of non-pharmaceuticals leave the quality burden on manufacturer, and is rarely fulfilled.
Both licensing programmes, offered to only discerning hair restoration clinics. enable the creation of differentiated therapies such as 0.3% topical bimatoprost, or 50mg of standardised oral procyanidin B2 that are found nowhere else - in addition to mainstream therapies like finasteride. Clinics generating profits and improve outcomes while staying focused on what they do best.
With research into androgenetic alopecia growing exponentially, the gap between pharmacology treatments patients receive and what they deserve is widening. Mainstream telemedicine is lagging, and the regulatory landscape of non-pharmaceuticals leave the quality burden on manufacturer, and is rarely fulfilled.
Both licensing programmes, offered to only discerning hair restoration clinics. enable the creation of differentiated therapies such as 0.3% topical bimatoprost, or 50mg of standardised oral procyanidin B2 that are found nowhere else - in addition to mainstream therapies like finasteride. Clinics generating profits and improve outcomes while staying focused on what they do best.
FAQs
Programmes & Scope
What exactly is Turnkey Bespoke Licensing?
Does it replace the traditional product purchase model?
What if I already have a brand set up?
Can we white label the existing systemK11 formulation?
What are the two programme paths?
Who is this for?
What do we control?
What does systemK11 contain?
Can we customise formulas?
Commericials
What are the one-time onboarding fees?
How much of the profits do clinics keep?
Are there minimum orders or commitments?
Who owns the brand rights?
FAQs
Programmes & Scope
What exactly is Turnkey Bespoke Licensing?
Does it replace the traditional product purchase model?
What if I already have a brand set up?
Can we white label the existing systemK11 formulation?
What are the two programme paths?
Who is this for?
What do we control?
What does systemK11 contain?
Can we customise formulas?
Commericials
What are the one-time onboarding fees?
How much of the profits do clinics keep?
Are there minimum orders or commitments?
Who owns the brand rights?
FAQs
Programmes & Scope
What exactly is Turnkey Bespoke Licensing?
Does it replace the traditional product purchase model?
What if I already have a brand set up?
Can we white label the existing systemK11 formulation?
What are the two programme paths?
Who is this for?
What do we control?
What does systemK11 contain?
Can we customise formulas?
Commericials
What are the one-time onboarding fees?
How much of the profits do clinics keep?
Are there minimum orders or commitments?
Who owns the brand rights?
© 2025. All Rights Reserved.
Registered in England, Company No. 12114910. Registered address 17 Blanchard Close, London, United Kingdom, SE9 4TZ